热毒宁治疗小儿急性上呼吸道感染伴发热的临床疗效分析

Clinical Analysis of Reduning in the Treatment of Children with Acute Upper Respiratory Infection with Fever

目的:探讨热毒宁治疗小儿急性上呼吸道感染(AURI)伴发热的临床疗效。方法:随机抽取2015年7月~2016年6月期间某院收治的急性上呼吸道感染伴发热患儿104例行对照实验,将患者分为两组,其中观察组(n=52例)患儿采用热毒宁治疗,而对照组(n=52例)患儿采用病毒唑治疗,对比分析不同治疗方案的临床治疗效果。结果:观察组临床疗效高于对照组(P<0.05),观察组患儿体温恢复正常时间低于对照组(P<0.05);两组患儿治疗期间均未出现明显不良反应情况。结论:小儿AURI伴发热采用热毒宁治疗临床疗效确切,值得临床进一步推广使用。

Objective：To investigate the clinical efficacy of Reduning in the treatment of acute upper respiratory infection （AURI） with fever in children.Methods：A total of 104 children with acute upper respiratory tract infection with fever were enrolled in this study from July 2015 to June 2016.The patients were divided into two groups： the observation group and control group （n=52 cases）.The observation group was treated with Reduning, the control group was treated with ribavirin,then compare the clinical treatment of different treatment regimens.Results：The clinical curative effect of the observation group was higher than that of the control group （P〈0.05）.The normal time of body temperature recovery in the observation group was lower than that in the control group （P〈0.05）.There was no obvious adverse reaction in the treatment group.Conclusion： The clinical efficacy of Children with AURI fever treated with Reduning treatment of is accurate, which is worthy of further clinical use.